Inloggen
E-mail
Wachtwoord
Paswoord weergeven
Bewaren
Bent u uw wachtwoord vergeten?
Gratis lid worden
Registreer
Registreer
Instellingen
Instellingen
Dynamische koersen 
OFFON

Toonaangevende leiders

Alle informatieOndernemingenMarktenEconomie & ForexgrondstoffenRenteToonaangevende leidersFinanciŽle professionalAgendaSectoren 
HomepaginaAl het nieuwsHet meest gelezen nieuwsBiografieŽn van de Leiders
Portrait de Thomas Henry Glocer
Leeftijd : 60
Vermogen : 10 026 610 USD
Belangrijkste bedrijven : Morgan Stanley - Merck & Co., Inc. - Publicis Groupe S.A.
Overzicht 
Thomas Henry Glocer is an American entrepreneur and businessperson who founded Angelic Ventures LP, BlueVoyant LLC and Communitas Capital Partners LLC and who has been at the helm of 6 different companies. Mr. Glocer holds the position of Executive Chairman for BlueVoyant LLC, Chief Executive Officer for Blueteam Investor LLC and Partner at Communitas Capital Partners LLC. Thomas Henry Glocer is also Member-Presidents Council International Activities at Yale University, Member-Madison Council at The Library of Congress (District of Columbia), Member of Supreme Court of the United States, Member of New York State Bar Association, Member of The American Law Institute, Member of The Business Council, Member of European Business Leaders' Convention and Managing Partner at Angelic Ventures LP and on the board of 12 other companies.

In the past he was Chief Executive Officer for Capitolis, Inc., Chief Executive Officer & Director at Reuters Group Plc, Chief Executive Officer for Thomson Reuters Plc, Chief Executive Officer & Director at Thomson Reuters Corp., Vice President & Deputy Counsel at Reuters America Holdings, Inc., Director at Council on Foreign Relations, Inc. and Member-International Business Council at Forum Mondial de L'Economie.

Mr. Glocer received an undergraduate degree from The Trustees of Columbia University in The City of New York and a graduate degree from Yale University.


Posities en verantwoordelijkheden van Thomas Henry Glocer 
NaamTitel Van
Morgan Stanley
(Diensten op het gebied van investeringsbankieren & makelaardij)
Lead Independent Director 2017
Merck & Co., Inc.
(Farmaceutische producten)
Independent Director 2007
Publicis Groupe S.A.
(Reclame & Marketing)
Member-Supervisory Board 2015
Blueteam Investor LLC Chief Executive Officer -
BlueVoyant LLC Executive Chairman 2017
The International Business Council Director 2011
The Atlantic Council of the United States Director -
The Cleveland Clinic Foundation Trustee -
Merck Sharp & Dohme Corp. Director 2009
K2 Intelligence LLC Director -
K2 Intelligence, Inc. Director 2012
Verto Analytics, Inc. Director -
Verto Analytics Oy Director -
Reynen Court LLC Non-Executive Director -
Yale University Member-Presidents Council International Activities 2011
The Library of Congress (District of Columbia) Member-Madison Council -
Supreme Court of the United States Member 2010
New York State Bar Association Member 1984
The American Law Institute Member 2011
The Business Council Member -
European Business Leaders' Convention Member 2013
Angelic Ventures LP Managing Partner 2012
Communitas Capital Partners LLC Co-Founder, Partner 2017


Belangnemingen van Thomas Henry Glocer 
NaamAandelen%Totale waarde
Morgan Stanley (MS)
(Diensten op het gebied van investeringsbankieren & makelaardij)
92 2870,0051%9 637 531 USD
Merck & Co., Inc. (MRK)
(Farmaceutische producten)
5 1000,0002%389 079 USD


Thomas Henry GlocerPersoonlijk netwerk 
Meest gelezen nieuws 
22/09WILLIAM ACKMAN : Ackman's Pershing Square fonds stijgt bij beursdebuut Universal
MR
24/09CATHIE WOOD : Chinese maatregelen tegen bitcoin opnieuw een klap voor Cathie Woods ARK ETF
MR
15/09BRAD SMITH : Microsoft kondigt inkoop van eigen aandelen aan tot $60 mrd, verhoogt dividend
MR
14/09STEPHEN SCHERR : Goldman Sachs benoemt Coleman als nieuwe CFO, ter vervanging van Scherr
MR
15/09ILHAM KADRI : Activist Bluebell Capital wil ontslag CEO Solvay
AM
Meer nieuws


© 2021 People and Ownership :   
Thomas Henry Glocer Verbindingen